Cargando…
Concomitant Obesity and Metabolic Syndrome Add to the Atrial Arrhythmogenic Phenotype in Male Hypertensive Rats
BACKGROUND: Besides hypertension, obesity and the metabolic syndrome have recently emerged as risk factors for atrial fibrillation. This study sought to delineate the development of an arrhythmogenic substrate for atrial fibrillation in hypertension with and without concomitant obesity and metabolic...
Autores principales: | Hohl, Mathias, Lau, Dennis H., Müller, Andreas, Elliott, Adrian D., Linz, Benedikt, Mahajan, Rajiv, Hendriks, Jeroen M. L., Böhm, Michael, Schotten, Ulrich, Sanders, Prashanthan, Linz, Dominik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634308/ https://www.ncbi.nlm.nih.gov/pubmed/28919580 http://dx.doi.org/10.1161/JAHA.117.006717 |
Ejemplares similares
-
Pharmacological inhibition of sodium-proton-exchanger subtype 3-mediated sodium absorption in the gut reduces atrial fibrillation susceptibility in obese spontaneously hypertensive rats
por: Linz, Benedikt, et al.
Publicado: (2020) -
Obstructive Sleep Apnea and Atrial Arrhythmogenesis
por: Hohl, Mathias, et al.
Publicado: (2014) -
Cathepsin A Mediates Ventricular Remote Remodeling and Atrial Cardiomyopathy in Rats With Ventricular Ischemia/Reperfusion
por: Hohl, Mathias, et al.
Publicado: (2019) -
Inhibition of sodium-proton-exchanger subtype 3-mediated sodium absorption in the gut: A new antihypertensive concept
por: Linz, Benedikt, et al.
Publicado: (2020) -
Late-onset thyrotoxicosis after the cessation of amiodarone()
por: Middeldorp, Melissa E., et al.
Publicado: (2020)